Literature DB >> 15452166

Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum?

K Baker1, Y Zhang, C Jin, J R Jass.   

Abstract

BACKGROUND: Because of their suggested link with microsatellite instability high colorectal cancers, right sided hyperplastic polyps (HPs) may differ from their distally located counterparts. This is highlighted by the recognition of a variant HP, termed sessile serrated adenoma (SSA), which predominates in the proximal colon. HPs displaying the morphological features now associated with SSAs have been shown to have altered expression of "cancer associated" markers, but no studies have investigated whether this is dependent on anatomical location of the polyps. AIMS: To evaluate morphological and functional features in right versus left sided HPs from patients without colorectal cancer with the aim of identifying distinguishing characteristics.
METHODS: HPs originating in the proximal and distal colorectum were histochemically and immunohistochemically stained to evaluate a panel of markers related to proliferation and differentiation. In addition, a series of morphological features was evaluated for each polyp.
RESULTS: Crypt serration, crypt dilatation, and horizontal crypt growth were more common among HPs from the right side, whereas histochemical factors including mucin changes, global methylation status, and expression of carcinoembryonic antigen were not significantly different. An age disparity was also seen between patients with right versus left sided lesions, with patients with right sided lesions being an average of more than 10 years younger than those with left sided lesions.
CONCLUSIONS: These findings suggest that right and left sided HPs differ mainly in terms of growth regulation rather than cellular differentiation, implying that these lesions belong to a continuous spectrum of serrated polyps that differ quantitatively rather than qualitatively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452166      PMCID: PMC1770443          DOI: 10.1136/jcp.2004.016600

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  43 in total

1.  B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway.

Authors:  P Erhardt; E J Schremser; G M Cooper
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Relationship between grade of microsatellite instability and target genes of mismatch repair pathways in sporadic colorectal carcinoma.

Authors:  G Togo; Y Shiratori; M Okamoto; Y Yamaji; M Matsumura; T Sano; T Motojima; M Omata
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

3.  Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer.

Authors:  Vicki L J Whitehall; Coral V A Wynter; Michael D Walsh; Lisa A Simms; David Purdie; Nirmala Pandeya; Joanne Young; Stephen J Meltzer; Barbara A Leggett; Jeremy R Jass
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

4.  Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

Authors:  Noralane M Lindor; Lawrence J Burgart; Olga Leontovich; Richard M Goldberg; Julie M Cunningham; Daniel J Sargent; Catherine Walsh-Vockley; Gloria M Petersen; Michael D Walsh; Barbara A Leggett; Joanne P Young; Melissa A Barker; Jeremy R Jass; John Hopper; Steve Gallinger; Bharati Bapat; Mark Redston; Stephen N Thibodeau
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

5.  Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas.

Authors:  N J Hawkins; R L Ward
Journal:  J Natl Cancer Inst       Date:  2001-09-05       Impact factor: 13.506

6.  Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability.

Authors:  Y-H Kang; S I Bae; W H Kim
Journal:  J Cancer Res Clin Oncol       Date:  2002-01-25       Impact factor: 4.553

Review 7.  The impact of chromatin in human cancer: linking DNA methylation to gene silencing.

Authors:  Esteban Ballestar; Manel Esteller
Journal:  Carcinogenesis       Date:  2002-07       Impact factor: 4.944

8.  The relationship between hypomethylation and CpG island methylation in colorectal neoplasia.

Authors:  Carolyn Bariol; Catherine Suter; Kay Cheong; Su-Lyn Ku; Alan Meagher; Nicholas Hawkins; Robyn Ward
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

Review 9.  DNA methylation in cancer: too much, but also too little.

Authors:  Melanie Ehrlich
Journal:  Oncogene       Date:  2002-08-12       Impact factor: 9.867

10.  Morphologic reappraisal of serrated colorectal polyps.

Authors:  Emina Torlakovic; Eva Skovlund; Dale C Snover; Goran Torlakovic; Jahn M Nesland
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

View more
  15 in total

Review 1.  Colorectal cancer molecular biology moves into clinical practice.

Authors:  Colin C Pritchard; William M Grady
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

2.  Differential expression of p53 and p504s in hyperplastic polyp, sessile serrated adenoma and traditional serrated adenoma.

Authors:  Nye-Thane Ngo; Emile Tan; Paris Tekkis; David Peston; Patrizia Cohen
Journal:  Int J Colorectal Dis       Date:  2010-07-17       Impact factor: 2.571

Review 3.  DNA alkylation and DNA methylation: cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas?

Authors:  William M Grady; Cornelia M Ulrich
Journal:  Gut       Date:  2007-03       Impact factor: 23.059

4.  The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum.

Authors:  Kristin Wallace; Maria V Grau; Dennis Ahnen; Dale C Snover; Douglas J Robertson; Daus Mahnke; Jiang Gui; Elizabeth L Barry; Robert W Summers; Gail McKeown-Eyssen; Robert W Haile; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

Review 5.  Molecular alterations and biomarkers in colorectal cancer.

Authors:  William M Grady; Colin C Pritchard
Journal:  Toxicol Pathol       Date:  2013-10-31       Impact factor: 1.902

Review 6.  The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening.

Authors:  William M Grady; Sanford D Markowitz
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

7.  The side of the primary tumor affects overall survival in colon adenocarcinoma: an analysis of the national cancer database.

Authors:  M C Turner; D Becerra; Z Sun; J Watson; K Leung; J Migaly; C R Mantyh; D G Blazer
Journal:  Tech Coloproctol       Date:  2019-06-12       Impact factor: 3.781

8.  Location in the large bowel influences the APC mutations observed in FAP adenomas.

Authors:  O C Will; S J Leedham; G Elia; R K S Phillips; S K Clark; I P M Tomlinson
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

9.  Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?

Authors:  Iradj Sobhani; Aurelien Amiot; Yann Le Baleur; Michael Levy; Marie-Luce Auriault; Jeanne Tran Van Nhieu; Jean Charles Delchier
Journal:  Therap Adv Gastroenterol       Date:  2013-05       Impact factor: 4.409

10.  Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps.

Authors:  Angela N Bartley; Patricia A Thompson; Julie A Buckmeier; Carole Y Kepler; Chiu-Hsieh Hsu; Manuel S Snyder; Peter Lance; Achyut Bhattacharyya; Stanley R Hamilton
Journal:  Mod Pathol       Date:  2009-10-23       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.